Conclusion
In our study, SARS-CoV-2 infected pregnant patients experienced more
obvious inflammatory response, cellular immune deficiency and potential
tissue necrosis. These may reflect the potential severity of the disease
course in pregnancy, but the clinical outcomes are similar between the
two groups.
No
evidence of neonatal infections and complications had been shown in this
study. Timely, intensive, active management and surveillance activities
from multidisciplinary medical cooperation may be beneficial for
improving the outcomes of pregnant women confirmed to have SARS-CoV-2
infection and the neonates.